Filing Details
- Accession Number:
- 0001415889-21-002578
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-19 20:18:47
- Reporting Period:
- 2021-05-18
- Accepted Time:
- 2021-05-19 20:18:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1750284 | Olema Pharmaceuticals Inc. | OLMA | Pharmaceutical Preparations (2834) | 300409740 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1831215 | Kinney Horn | C/O Olema Pharmaceuticals, Inc. 512 2Nd Street, 4Th Floor San Francisco CA 94107 | Chief Business Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-18 | 57,763 | $2.06 | 59,553 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-05-18 | 49,142 | $24.03 | 10,411 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-05-18 | 8,621 | $24.81 | 1,790 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-05-18 | 57,763 | $0.00 | 57,763 | $2.06 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 194,297 | 2030-06-09 | No | 4 | M | Direct |
Footnotes
- Includes 1,790 shares acquired under the issuer's Employee Stock Purchase Plan on May 14, 2021.
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- The weighted average sale price for the transaction reported was $24.03, and the range of prices were between $23.51 and $24.50. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $24.81, and the range of prices were between $24.52 and $25.23. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.
Billionaire Hedge Funds
